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Abstract: The aim of this study was to investigate the presence and distribution of proteoglycans within Meckel’s carti-
lage of rat embryos. A standard indirect immunoperoxidase technique was used on paraffin sections of rat heads. Sections 
were incubated with monoclonal antibodies recognising core protein epitopes in the proteoglycans versican and CD44. 
Polyclonal antibodies localized the proteoglycans decorin, biglycan and lumican. Versican was expressed by chondro-
cytes, but very weekly by the extracellular matrix. Decorin was strongly expressed by both of chondrocytes and the ECM. 
Both of biglycan and lumican were moderately expressed by chondrocytes, but weakly by the extracellular matrix. CD44 
was weakly expressed by chondrocytes only, without staining of the ECM. It is concluded that Meckel’s cartilage chon-
drocytes express the proteoglycans versican, decorin, biglycan, lumican and CD44 at variable levels during development 
in the rat. Such data are important for a greater understanding of the changes that take place during mandibular develop-
ment. Further studies are needed to elucidate the exact role of proteoglycans during Meckel’s cartilage and mandibular or-
ganogenesis.  
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INTRODUCTION  
  Proteoglycans (PG) are a group of macromolecules each 
composed of a core protein to which one or more highly ani-
onic glycosaminoglycan (GAG) chains are attached through 
a specific sequence of trisaccharides: galactose-galactose-
xylose. Proteoglycans play essential roles in the develop-
ment, maintenance of function and integrity of virtually all 
tissues [1]. They are pivotal in cell-cell, and cell-extra- 
cellular matrix (ECM) interactions, e.g. control of minerali-
zation, control of collagen fibrillogenesis, in addition to act-
ing as cell-surface receptors [2]. Furthermore, PG are be-
lieved to govern the process of cell movement in numerous 
physiological and pathological conditions [3].  
  During normal embryonic development in mammals, the 
mandible is formed from the mandibular process of the first 
branchial arch. The mesenchyme of the mandibular process 
is derived from cranial neural crest cells, and paraxial meso-
derm [4]. While the mesoderm gives rise to muscular and 
vascular tissues, the neural crest cells give rise to the man-
dibular arch skeleton, including Meckel’s cartilage [4]. The 
mandibular bone develops by intramembranous osteogenesis 
lateral to Meckel’s cartilage. Meckel’s cartilage is a pair of 
cylindrical rods of hyaline cartilage that give rise at their 
proximal ends to the malleus and incus of the middle ear [5]. 
The rostral (anterior to the mental foramen) and auricular 
(extending to the malleus) ends undergo endochondral type 
osteogenesis; the entire middle portion gets resorbed in the 
absence of any obvious formation of a calcified matrix and 
these cells undergo terminal cellular hypertrophy. However,  
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the mid portion of the soft tissue of Meckel’s cartilage, at the 
degenerating stage, gives rise to the sphenomandibular liga-
ment [6]. It has been demonstrated that chondroitin sulphate 
proteoglycans (CSPG), namely the hyaluronan (HA)-binding 
PG aggrecan, are the main PG of hyaline cartilage [7]. 
Decorin, biglycan, fibromodulin and epiphycan have also 
been localised to hyaline cartilage [8]. These PG have been 
ascribed several important roles such as ECM assembly, 
control of mineralisation and acting as cell surface receptors. 
Temporo-spatial variation of PG expression and composition 
during embryogenesis regulate tissue formation and integ-
rity. For example, quail embryonic aggrecan has been shown 
to curtail the ability of neural crest cells to migrate within 
tissues [9]. Similar roles may be played by Meckel’s carti-
lage PG. It is still unclear how Meckel’s cartilage influences 
the surrounding developing mandibular bone. However, PG 
in Meckel’s cartilage appear to be essential in maintaining 
the cartilage in an un-mineralized state, for certain periods of 
time. PG may also be involved in communication with the 
surrounding mesenchymal tissues.  
  Epithelial-mesenchymal interactions play a pivotal role 
in histogenesis during mandibular development. Such inter-
actions are mediated by the expression of various signalling 
molecules, such as PG and their components; the glycosami-
noglycans (GAG) [10]. Animal studies, utilising 3-dimen- 
sional reconstruction, indicate that the mandible mainly 
grows at its periphery, and that this growth is regulated by 
paracrine signalling from Meckel’s cartilage and the devel-
oping tooth buds [11]. This signalling is probably mediated 
by a variety of macromolecules such as transforming growth 
factors-beta (TGF- ), bone morphogenetic proteins (BMP) 
and PG [11]. In an attempt to understand the role of PG in 
the development of the growing mandible, this study was 
conducted to investigate the expression and distribution of a  
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number of PG species at Meckel’s cartilage during in utero 
development in a mouse model utilising immunohistochem-
istry.  
MATERIALS AND METHODS 
Antibodies 
  Paraformaldehyde and sodium cacodylate (BDH Chemi-
cal Ltd Poole, England) were used for tissue fixation. A 
sledge base microtome (Leitz) was used to cut sections. For 
immunolocalization, a kit utilising a standard indirect im-
munoperoxidase method was used (Vectastain Quick kit, 
Vector Lab., California). The enzyme chondroitinase ABC 
(Sigma Chemical CO) was used to increase accessibility of 
the antibodies to their epitopes. Well-characterised antibod-
ies were used and are listed in Table 1. These include the 
monoclonal (MAb) antibody 12C5 against versican, the 
polyclonal antibody (PAb) LF-113 against murine decorin, 
the (PAb) LF-106 against murine biglycan, a PAb recognis-
ing the core protein of lumican, and the MAb Hermes I 
against CD44.  
METHODS 
Tissue Preparation 
  This animal study was reviewed and approved by the 
institutional ethics committee. The specimens examined in-
cluded rat heads of embryonic stages E18, E19 and E20, 
corresponding to post conception days 18, 19 and 20. These 
were fixed in 4% paraformaldehyde and 0.1 M Na cacody-
late buffer for up to 48 h at 4°C. The specimens were dehy-
drated in 90% ethanol, embedded in paraffin wax, and 5-10 
μm sections were cut. To observe normal histology, haema-
toxylin and eosin sections were prepared for light micro-
scopic examination. 
Immunohistochemical Staining 
  Prior to staining, the sections were de-paraffinized in 
xylene and rehydrated for 5 min in descending concentra-
tions of alcohol (100% twice, 95% and 70% ethanol), water 
and PBS. To increase antibody access to epitopes, sections 
were pre-treated with chondroitinase ABC 0.1 IU/mL 
(Sigma) in 0.1 M Tris buffer containing 0.1% BSA, pH 7.2 
at 37°C for 1 h. After enzymatic pre-treatment the sections 
were rinsed thoroughly in PBS and Tween (Polyoxyethylene 
20 sorbitan monolaurate, Fisher Scientific Ltd., Loughbor-
ough, UK) for 15 min, and incubated for 5 min with 3% 
H2O2 in water to eliminate endogenous peroxidase activity. 
The sections were incubated for 10 min in working solution 
of normal horse serum, (Vectastain Quick kit, Vector lab., 
California) in order to block background staining. Primary 
antibodies were added at working concentrations, which are 
presented in Table 1. These antibodies were all diluted in 
PBS buffer containing 1.5% horse serum (Vectastain Quick 
kit, Vector lab., California), and left on the sections for 60 
min at room temperature. The slides were rinsed twice in 
PBS and Tween for 5 min and incubated with the biotiny-
lated secondary antibody (raised in horse and recognises 
rabbit, mouse, goat, bovine and sheep IgG, Vectastain Quick 
kit, Vector Lab., California) for 10 min at room temperature. 
After two 5-min rinses in PBS and Tween, the sections were 
incubated in streptavidin/peroxidase complex solution for 5 
min (Vectastain Quick kit, Vector lab., California) and 
rinsed as above. The sections were then incubated with the 
peroxidase substrate solution, containing diaminobenzidine 
(DAB) until the brown stain developed intensely. The sec-
tions were thoroughly rinsed with double distilled water, 
counterstained with haematoxylin and rinsed in water, PBS 
and water again. They were dehydrated in ethanol, cleared in 
xylene and mounted for LM examination. Photomicrographs 
were taken with Leica microscope, using Kodak Ektachrome 
films.  
Controls 
  Positive and negative control sections were used. With 
polyclonal (rabbit) antibodies against decorin, biglycan and 
lumican, some negative control sections were incubated with 
normal rabbit serum (concentration 1:1000, Sigma), which 
does not interact with the tissues studied. With monoclonal 
antibodies, serum or mouse immunoglobulin (MIG, Sigma, 
concentration 1:500) were used instead of the primary anti-
bodies. Other sections were incubated with PBS in place of 
the primary antibody. The developing tooth buds in each 
section were used as positive/negative control tissues, based 
on findings of previous studies [16, 17]. 
Table 1.  Details of the Antibodies Used in this Investigation 
Antibody Epitope  Type  Dilution  Source  Reference 
12C5 
Hyaluronate binding  
region of versican 
Monoclonal mouse IgG1  1 : 200 
Purchased from Dr. R.A. Asher, Developmental 
Studies Hybridoma Bank, Iowa, USA 
Asher et al. [12]
 
LF-113 
Core protein epitopes of 
 murine decorin 
Polyclonal rabbit IgG  1 : 100 
A generous gift from Professor L. Fisher,  
National Institute of Health, USA 
Fisher et al. [13]
 
LF-106 
Core protein epitopes of  
murine biglycan 
Polyclonal rabbit IgG  1 : 100 
A generous gift from Professor L. Fisher,  
National Institute of Health, USA 
Fisher et al. [13]
 
Anti-lumican  Core protein epitopes  Polyclonal, rabbit IgG  1 : 200 
A generous gift from Professor J R Hassel, 
University of Pittsburgh, Pennsylvania, USA 
Chakravarti et al. [14]
 
Hermes 1 
The N-terminal Hyaluronate  
binding domain of CD44 
Monoclonal rat IgG2  1:10 
Developmental Studies Hybridoma Bank,  
Iowa, USA 
Picker et al. [15]
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RESULTS 
Immunolocalization of Versican 
  After incubation with MAb 12C5 and chondroitinase 
ABC pre-treatment, the following results were obtained (Fig. 
1A, B, C). At E18 there was a positive staining of chondro-
cytes of Meckel’s cartilage. Similar distribution and intensity 
of staining were observed in the E19 and E20 rat embryos. In 
all embryonic stages, there was only very weak staining of 
the ECM.  
Immunolocalization of Decorin  
  Following incubation with LF-113 (a PAb which specifi-
cally recognises murine decorin), and chondroitinase ABC 
pre-digestion, an intense positive staining of chondrocytes 
and ECM of Meckel’s cartilage was observed at the embry-
onic stages E18, E19 and E20 (Fig. 1D, E, F).  
Immunolocalization of Biglycan  
  Following incubation with LF-106 (a PAb which specifi-
cally recognises murine biglycan), with chondroitinase ABC 
pre-digestion, positive staining of chondrocytes was ob-
served at E18. More intense staining was evident at E19 and 
E20. The ECM was mildly stained at the three stages (E18 to 
20) (Fig. 1G, H, I). 
Immunolocalization of Lumican  
  Following incubation of sections with the PAb recognis-
ing core protein epitopes in lumican, at the E18 stage, weak 
immunoreactivity was observed in the chondrocytes and 
ECM of Meckel’s cartilage. E19 cartilage showed moderate 
immunoreactivity, and at E20 Meckel’s cartilage showed 
strong immunoreactivity. The ECM was mildly stained at the 
three stages (E18 to 20) (Fig. 1J, K, L). 
Immunolocalization of CD44  
  After incubation of sections with MAb Hermes 1, which 
recognises CD44, very weak immunoreactivity was observed 
on chondrocytes at the periphery of Meckel’s cartilage at the 
three stages examined (E18-E20). No evidence of staining 
could be seen in the ECM (Fig. 1M, N, O).  
Controls 
  Control sections where the primary antibody was substi-
tuted with PBS, mouse immunoglobulin or rabbit serum, 
were all negative (Fig. 1P). The developing tooth buds and 
dental tissues, such as the pulp and dentine in each section, 
which were used as positive/negative control sections (Fig. 
1Q, R), exhibited findings consistent with previous studies 
[16, 17]. 
DISCUSSION 
  During intra uterine life, the ECM of Meckel’s cartilage 
remodels by the action of proteolytic enzymes secreted by its 
own chondrocytes, and most of the cartilage disintegrates 
soon after the onset of mandibular bone formation. Although 
it is generally accepted that Meckel’s cartilage is essential 
for mandibular growth and development, the exact role of 
this cartilage, and thus, the roles of the tissue factors ex-
pressed within it, are still unclear.  
  The midportion of Meckel’s cartilage in rats and mice 
disappears soon after birth, probably by cellular resorption of 
the chondrocytes in the anterior part of the midportion, and 
by differentiating into fibroblastic cells in the posterior part 
of the midportion [18]. In the present study, we have selected 
rat embryonic stages E18-E20 (usually, the last gestational 
day) before any disintegration of the cartilage rods, or trans-
formation of the chondrocytes into fibroblasts within the 
midportion of Meckel’s cartilage has taken place. It is ex-
pected that in newborn rats the anterior part of the midpor-
tion of Meckel’s cartilage may be completely missing, and 
changes in the posterior part of the midportion may have 
started [18]. Therefore, in the present work only embryonic 
Meckel’s cartilage was studied. Most previous studies have 
investigated earlier stages Meckel’s cartilage; for example, 
Lee et al. [19] investigated Meckel’s cartilage at embryonic 
days 15-18. Moreover, some PG like versican could not be 
detected at earlier embryonic stages such as E15 [19]. Our 
aim was to investigate PG in Meckel’s cartilage at later em-
bryonic stages just before chondrocyte transformation, or 
disappearance, have occurred.  
  Meckel’s cartilage chondrocytes share many phenotypic 
characteristics with other cartilaginous cells. However, they 
show some differences from trunk cartilage chondrocytes. 
For example, Meckel’s cartilage chondrocytes are the only 
cartilage cells that are capable of producing type I collagen 
in tissue cultures [6]. This probably reflects the different 
origins of this cartilage as, unlike other cartilage, which is 
derived from mesoderm, Meckel’s cartilage originates from 
neural crest ectomesenchyme [6]. We have shown that the 
PG species versican, the small leucine-rich proteoglycans 
(SLRPs) decorin, biglycan and lumican, and the cell surface 
HA-binding PG CD44 are present in Meckel’s cartilage of 
the rat during in utero mandibular development with variable 
degrees. Although CSPG have previously been shown to be 
present in Meckel’s cartilage [2], to date, this is first study to 
describe the expression of a wide range of PG in Meckel’s 
cartilage.  
  Versican (also known as PG-M) is a large CSPG of the 
ECM. In various developing embryonic tissues, versican is 
transiently expressed and plays important roles in cell adhe-
sion [20], migration [21], proliferation, and differentiation 
[22]. It localizes in various tissues both in fetal and adult 
animals [21, 23-25]. In particular, it is expressed in prechon-
drogenic mesenchyme, and during the transition to cartilage 
its expression becomes restricted to the periphery of the 
newly formed cartilage [21]. In addition, versican has been 
isolated from rat dental pulp [26], periodontium [27], and 
developing mandibular condylar cartilage [28]. It has been 
suggested that versican is involved in positively regulating 
the formation of the mesenchymal matrix and the onset of 
chondrocyte differentiation through the attached chondroitin 
sulfate chains [29]. Another study [30] strongly suggests that 
mature versican is essential for precartilage aggregation and 
subsequent cartilage differentiation. 
  In developing cartilage, versican is transiently expressed 
at a high level in the mesenchymal condensation area and 
rapidly disappears during cartilage development [31]. Im-
munohistochemical studies on developing limb bud cartilage 
revealed that an area positive for versican gradually shifts 
out of the diaphysis and is replaced by an area positive for 180    The Open Dentistry Journal, 2009, Volume 3  Ababneh and Al-Khateeb 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Immunoperoxidase staining for Versican showing positive staining of moderate intensity on Meckel’s cartilage chondrocytes and 
weak staining within the ECM at all embryonic stages (A, B, C). Decorin showed an intense positive staining on chondrocytes and within the 
ECM at all embryonic stages (D, E, F). Biglycan was moderately expressed at E18 (G), and more intense staining at later stages (H, I). Stain-
ing for Lumican on the chondrocytes and ECM was weak at E18 (J), moderate at E19 (K), and intense at E20 (L). Immunoperoxidase stain-
ing for CD44 showed very weak staining on chondrocytes at all stages, without any staining within the ECM (M, N, O). P, Q and R represent 
the control sections.  
P: negative control section; Q: positive staining for biglycan in the enamel organ and dental papilla of a developing molar tooth bud at the 
E19 stage; R: positive staining for decorin in the dental papilla, odontoblasts and dentin in a developing tooth bud. OOE: outer enamel epi-
thelium; SR: stellate reticulum; IEE: inner enamel epithelium; dp: dental pulp, df: dental follicle. Proteoglycans in Meckel’s Cartilage  The Open Dentistry Journal, 2009, Volume 3    181 
 
aggrecan [24]. Differentiating chondrocytic cells showed 
similar expression patterns of these molecules [29]. There-
fore, it was generally accepted that mature chondrocytes do 
not express versican (but express aggrecan). However, al-
though versican has not been detected by immunohisto-
chemical studies, constitutive low level transcription of the 
versican gene has been observed in cartilage and chondro-
cytes [31, 32]. Furthermore, biochemical studies demon-
strated the presence of versican in human articular cartilage 
from the fetal stage to mature adult [33]. Unlike previous 
immunohistochemical studies, we have demonstrated posi-
tive immunostaining of versican within chondrocytes of 
Meckel's cartilage. It is possible that the expression of versi-
can is a unique feature of Meckel's cartilage at later embry-
onic stages. 
  In the present study, versican was expressed by Meckel’s 
cartilage chondrocytes in all embryonic stages, with no 
changes detected in the intensity of staining as the embryos 
matured. Our findings are in general agreement with those of 
Ishizeki and Nawa [34], who demonstrated the expression of 
CSPG, using immunohistochemical methods, in addition to 
toluidine and Alcian blue staining. However, our findings 
contrast with those of Lee et al. [19], who were not able to 
demonstrate immunoreactivity to versican in Meckel’s carti-
lage. The reason for this disagreement may be that, in their 
study, Lee et al. [19] have included earlier stage Meckel’s 
cartilage (embryonic days 15 to 18), whereas in our study, 
later stages (E18 to E 20) were investigated. Another reason 
may be that Lee et al. [19] have used a different antibody. 
They have used the MAb (5D5) which recognises the core 
proteins of large PG, such as versican, neurocan and brevi-
can. The antibody used in our study (12C5) is a more spe-
cific antibody, which specifically recognises the HA-binding 
region of versican core protein.  
  The SLRPs belong to the large family of leucine-rich 
repeat proteins, which are characterized by multiple adjacent 
domains bearing a common leucine-rich motif. They can be 
divided into several sub-families based on their gene organi-
zation, the number of leucine-rich repeats and the type of 
GAG chain substituent. Decorin and biglycan are part of one 
subfamily, whereas fibromodulin and lumican are part of a 
second subfamily. The GAG chains have been associated 
with the interaction with several growth factors, and enable 
the SLRPs to provide a sink for growth factor accumulation 
within the extracellular matrix. The SLRPs can therefore, 
help modulate chondrocyte metabolism by regulating growth 
factor access to the cells [35].  
  Decorin and biglycan can be detected in fetal cartilage 
and bone [36]. Although decorin is involved in the organiza-
tion of collagen fibrils, in the modulation of collagen me-
tabolism and in interactions with various glycoproteins, reti-
noic acid and growth factors, e.g. TGF-  [37], the functions 
of biglycan are not well understood. It may participate in the 
control of chondrocyte proliferation [31]. In vitro studies of 
human articular cartilage have shown that the expression 
level of decorin increases and that of biglycan decreases with 
age [38]. Within developing bone, biglycan is localized to 
the walls of the osteocyte lacunae and bone cell surface, 
whilst decorin is present throughout the osteoid matrix and 
associated with bone cells associated with osteogenic and 
non-osteogenic layers of the periosteum [36]. We have found 
that decorin is expressed by chondrocytes and surrounding 
ECM without any change in intensity of staining in the three 
embryonic stages examined. As for biglycan, staining was 
less intense than decorin, but gradually increased throughout 
development. Similarly, Kavanagh and Ashhurst [39], inves-
tigating the immunolocalization of biglycan during devel-
opment and aging of articular cartilage in the rabbit knee 
joint, found that biglycan is present in the deeper regions of 
the epiphyseal cartilage, which eventually ossifies, but could 
not be detected in the interzone, the region from which the 
articular cartilage develops and maintains its cartilaginous 
nature after birth. Decorin and biglycan have been isolated 
from predentine, predentine-dentine interface and the miner-
alised dentine ECM [40]. Milan et al. [41] have demon-
strated that the composition and functions of decorin and 
biglycan differ with transition from the non-mineralised pre-
dentine towards the mineralised dentine matrix. Furthermore, 
it was found that with this transition from the non-
mineralised to mineralised dentine, there was an increasing 
affinity to hydroxyapatite, which was predominantly facili-
tated through GAG chains [42]. Based on the above findings, 
our results of a sustained expression of decorin and biglycan 
in Meckel’s cartilage might suggest a role of these SLRPs in 
inhibiting mineralisation of this cartilage.  
  In the present study, lumican was gradually upregulated 
throughout embryonic stages E18 to E20. In accordance with 
our results, Ying et al. [43] have demonstrated, using north-
ern plot and in situ hybridisation, that in earlier stages mouse 
embryos, there is almost no lumican expression, but that the 
expression of this PG increases with organ development and 
function.  
  CD44 is an adhesion molecule distinct from cadherin and 
integrins. This protein functions as a HA receptor and is in-
volved in cell migration [44]. In vitro studies suggest that 
CD44 is expressed in chondrocytes [45]. In the present 
study, CD44 was weakly expressed by Meckel’s cartilage 
chondrocytes. This pattern of CD44 expression in rat 
Meckel’s cartilage is different from that previously reported 
in rat tibial cartilage [46]. However, it is consistent with its 
distribution in the rat mandibular condylar cartilage [47]. 
Cranial bone and cartilage, including Meckel’s cartilage and 
mandibular condylar cartilage, originate in neural crest-
derived mesenchyme [48]. In contrast, bones and cartilage in 
limbs are derived from lateral plate mesoderm. Thus, 
Meckel’s cartilage has a different developmental origin from 
tibial cartilage. Therefore, the different pattern of CD44 ex-
pression observed in these two types of cartilage may be due 
to their different origins. In fact, CD44 is used as a marker of 
neural-crest-derived cells and embryonic stem cells [49].  
  The temporal expression of PG during various stages of 
development found herein, suggests that the expression of 
PG may be up- or down-regulated by chondrocytes as neces-
sary for cell-cell or cell-ECM signalling within Meckel’s 
cartilage, or between chondrocytes of Meckel’s cartilage and 
the surrounding mesenchymal tissues and developing alveo-
lar bone. Changes in the expression and chemical composi-
tion of various macromolecules, including PG and growth 
factors, are well-known events during histogenesis and 
morphogenesis of various tissues during orofacial develop-
ment, including mineralised tissues such as tooth dentine 
[40-42]. The very exact role of PG in Meckel’s cartilage 182    The Open Dentistry Journal, 2009, Volume 3  Ababneh and Al-Khateeb 
cannot be readily revealed from the present work, however, 
we postulated, based on the functions of PG reported by 
other studies [50] that Meckel’s cartilage PG may inhibit 
mineralization of the cartilage during mandibular develop-
ment, where signalling from Meckel’s cartilage chondro-
cytes and/or ECM is believed to be necessary for mandibular 
development, which may be mediated by PG. It is known 
that the functions of PG including SLRPs depend upon their 
core protein and GAG chains. SLRPs interact, via their core 
protein, with fibrillar collagen, thus regulating fibril diameter 
and fibril-fibril interactions. Attachment of core proteins to 
collagen also limits access of collagenase to its substrate, 
thereby protecting collagen from proteolytic action [50]. The 
function of SLRPs, such as decorin, biglycan and lumican is 
best illustrated by the abnormal phenotypes in knock-out 
mice. Inhibition of decorin expression was associated with 
thinning of the skin, accumulation of loose connective tissue 
in the subdermal layer, abrupt fracture and dissection of the 
skin between the deeper dermis and the fascia [51]. Biglycan 
knockout mice demonstrated reduced growth rate, decreased 
bone mass and differences in bone shape, when compared to 
normal mice [52]. Absence of lumican produces skin laxity 
and corneal opacity, with an increased proportion of abnor-
mally thick collagen fibrils and delayed corneal epithelial 
wound healing [53] Therefore, the PG of Meckel’s cartilage 
are probably involved in similar functions, including regula-
tion of collagen fibrillogenesis, preservation of Meckel’s 
cartilage integrity, inhibition of cell proliferation, inhibition 
of Meckel’s cartilage mineralization and possibly influenc-
ing the developing mandibular bone surrounding Meckel’s 
cartilage.  
  The results presented here show how the distributions of 
the PG versican, decorin, biglycan, lumican and CD44 vary 
during development in rat Meckel’s cartilage. In addition, 
they suggest that the Meckel’s cartilage chondrocytes are a 
distinct population of cells. Such data are important for a 
greater understanding of the changes that take place during 
mandibular development. Further studies are needed to elu-
cidate the exact role of PG during Meckel’s cartilage and 
mandibular organogenesis.  
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